Valens GroWorks Highlighted by AltaCorp Capital Executive Discussing Flourishing Cannabis Pharma Space
With the launch of a legal recreational cannabis market in Canada, as well as an established medical market, players in the financial and investment spaces have started to look favorably upon cannabis companies leading the industry. In a recent interview on MidasLetter Live, AltaCorp Capital Inc.’s Managing Director David Kideckel spoke about the launch of his company’s cannabis sector coverage, which includes recognizable names in Canada like Auxly Cannabis Group Inc. (TSXV:XLY) and Valens GroWorks Corp. (CSE:VGW).
Speaking of Valens, a Kelowna, BC-based, research-driven, vertically-integrated Canadian cannabis company focusing on cannabis extraction, distillation as well as cannabinoid isolation and purification, Kideckel highlighted the steps the company has taken to deploy its business model.
“We think [Valens is] one of the premier businesses in the entire cannabis sector focusing really on extraction, and that’s their core capability. They have leading partnerships with Thermofisher Scientific (NYSE:TMO), where they have a centre of excellence at their Kelowna operation, as well as the Canadian exclusive rights to a company called Tarukino – a US-based company that’s involved with beverages and looking at emulsification technology,” said Kideckel.
To read the full interview, click here.